
Ricardo Hosman Basto 🇨🇴🇦🇷🇮🇹
@hosmanbasto
Urologist, Renal & Prostatic Oncology, Minimally Invasive Surgery.
ID: 146704823
https://www.linkedin.com/in/ricardo-hosman-basto-ba5693138/ 22-05-2010 03:52:27
2,2K Tweet
264 Followers
660 Following

Read our European Urology Oncology editorial: a paradigm shift is necessary to #reenvision the #perspective on #offclamp procedures. 🔗 Link to full text 👇🏼 authors.elsevier.com/c/1iSOX9Cfv-xp…


Congratulations David E. Hinojosa-González M.D. 🙌 🔗 pubmed.ncbi.nlm.nih.gov/38242825/ #ProstateCancer #RadicalProstatectomy #ePLND



Hola @cfkargentina. Acabo de anular los aumentos de sueldo de todo el gabinete nacional. Ya que la vi tan preocupada por las jubilaciones ¿qué le parece si le anulo los $ 14.000.000 que cobra usted de jubilación de privilegio y le asigno una jubilación mínima? Estimo no va a

Disponible el manuscrito sobre la relación entre el virus del #papilomahumano (VPH) y el diagnóstico de #cancerdevejiga : revisión sistemática y metaanálisis ▶️ doi.org/10.1016/j.acur… AEU Confederación Americana de Urología (CAU) RAEU - Spanish Urology Residents Working Group Oficina Residentes CAU Óscar Rodríguez Faba European Association of Urology (EAU) Amer. Urol. Assn.


Quiero agradecerles por su atención durante mi participación en la presentación, resalté la importancia del diagnóstico temprano y las opciones de tratamiento disponibles para esta condición. Agradezco al comité organizador Asociación de Medicos de Santa Marta por brindarme esta oportunidad.



To Foley, or not to Foley, that is the question. Our European Section of Urolithiasis - EULIS & YAU ENDOUROLOGY collaboration article concludes that while Foley catheterization post-URS + DJ placement does not significantly improve biochemical outcomes, it may reduce postop pain doi.org/10.1111/bju.16…


Bladder sparing therapy, in carefully selected patients with BCG-unresponsive #BladderCancer, provides comparable survival in the intermediate term to upfront radical cystectomy. Jake Taylor, MD, MPH doi.org/10.1111/bju.16…



TiP - STAMPEDE2 177Lu-PSMA-617 Trial in new mHSPC UroToday.com MRC Clinical Trials Unit at UCL #ESMO24 🎯 n=1,756 ✏️1:1 to Arm A (SoC) vs Arm P (SoC + 177Lu-PSMA-617) - 177Lu-PSMA-617: 7.4 GBq on day 1 & day 8, 3x 6-weekly cycles ✏️Co-Prim EP: rPFS, OS ✏️Sec EP: FFS, PCSS, QoL, safety, tox, compliance,


⚡️ LBA ⚡️- ARANOTE: Efficacy & safety of Daro + ADT in mHSPC UroToday.com #ESMO24 Bayer Oncology Medical Daro + ADT vs PBO + ADT: 📌n=669; 446 Daro vs 223 PBO 📌Prim EP, rPFS: HR 0.54, 95% CI 0.41–0.71 📌OS: HR 0.81, 95% CI 0.59–1.12 📌TT CRPC: HR 0.40, 95% CI 0.32–0.51 📌TT PSA Prog: HR



Sure. Here is a short movie. Come join us at the clinic Nov 8 for the SP course and see more SP applications. Dr. J. Kaouk Cleveland Clinic Urology

Robotic surgery can be so fun sometimes. Like when you get something really cool that’s really easy to fix. How about a large stone in a ureterocele while doing a prostatectomy? Endourological Society

Testosterone recovery following treatment suspension of enzalutamide + leuprolide or leuprolide alone in patients with high-risk biochemically recurrent prostate cancer: #EMBARK post-hoc analysis. Presented by Stephen Freedland, MD Cedars-Sinai. #AUA25 written coverage by Rashid K. Sayyid USC



